Linked Life Data

15324529

Source:http://linkedlifedata.com/resource/pubmed/id/15324529

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2004-8-24
pubmed:abstractText
The effects of tacrolimus, a new immunosuppressive drug, which inhibits calcineurin pathway and also might enhance corticosteroid (CS) receptor-mediated gene expressions, on clinical outcome and biochemical data were evaluated in thymectomised and steroid-dependent myasthenia gravis (MG) patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0300-7995
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1269-73
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Low-dose tacrolimus treatment in thymectomised and steroid-dependent myasthenia gravis.
pubmed:affiliation
Department of Neurology, Chiba University Graduate School of Medicine, Chiba, Japan. kawaguchi@faculty.chiba-u.jp
pubmed:publicationType
Journal Article